| Application no. and date | 16152794.0 (espacenet) (Federated) (European Patent Register), 20080612 | | Patent/reg. no. and date | DK/EP 3070090, 20181212 | | Publication date | 20160921 | | Priority no. and date | US 943705 P, 20070613 | | EP pub. no. and date |
EP 3070090 20160921 | | Effective date | | | Applicant/owner | Incyte Holdings Corporation, 1801 Augustine Cut-Off
Wilmington, DE 19803, US | | Applicant ref. no. | P67612DK01 | | Inventor | RODGERS, James, D., 2 Hillside Lane
Landenberg, PA 19350, US,
LI, Hui-Yin, 176 Thompson Drive
Hockessin, DE 19707, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) , C07D 487/04 (2006.01) | | Title | ANVENDELSE AF SALTE AF JANUS-KINASE-INHIBITOREN (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H- PYRAZOL-1-YL)-3- CYCLOPENTYLPROPANNITRIL | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
